China: New chief innovation officer for 111

Anfeng Guo, a former vice president of the oncology business Unit at Bristol Myers Squibb has been named as chief innovation officer of Shanghai-based digital and mobile healthcare platform 111. Guo will oversee operations and innovation at the internet medical platform across the company. He will also manage 111 subsidiary Hanhong Pharmaceutical to help commercialise…

You must be a HMI Subscriber to view this content. Please log in or subscribe below.

Subscribe Now »